Current anti-doping policy: A critical appraisal

BMC Medical Ethics

Volumn 8, Issue , 2007, Pages

  Kayser, Bengt ^a   Mauron, Alexandre ^a   Miah, Andy ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; ILLICIT DRUG;

ACHIEVEMENT; ATHLETE; CONCEPT ANALYSIS; COST; DOPING; DRUG SCREENING; DRUG USE; ETHICS; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MEDICAL PROFESSION; PREVALENCE; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; SPORT; POLICY;

DOPING IN SPORTS; PUBLIC POLICY;

EID: 34247141049     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-8-2     Document Type: Review

References (60)

1. www.wada-ama.org. 2007 http://www.wada-ama.org
2. www.usantidoping.org. 2007 http://www.usantidoping.org
3. Banning Drugs in Sports: A Skeptical View'. N Fost, Hastings Cent Rep 1986 16 5 10 3744803
4. Doping in Sports and the Use of State Power. MJ Mehlman E Banger MM Wright, Saint Louis University Law Journal 2006 15 73
5. Why we should allow performance enhancing drugs in sport. J Savulescu B Foddy M Clayton, Br J Sports Med 2004 38 666 670 10.1136/bjsm.2003.005249 15562155
6. 'The technology of perfection: performance enhancement and the control of attributes. MH Shapiro, Southern California Law Review 1991 11 113 11645829
7. S Loland, Fair play in sport a moral norm system London, Routledge Ethics and sport. 2002
8. RL Simon, Fair play sports, values, and society Boulder, Westview Press 1991
9. The human gene map for performance and health-related fitness phenotypes: the 2003 update. T Rankinen L Perusse R Rauramaa MA Rivera B Wolfarth C Bouchard, Med Sci Sports Exerc 2004 36 1451 1469 10.1249/01.MSS.0000139902. 42385.5F 15354024
10. Molecular and cellular adaptation of muscle in response to physical training. FW Booth M Fluck BS Tseng JA Carson, Acta Physiologica Scandinavica 1998 162 343 350 10.1046/j.1365-201X.1998.0326e.x 9578380
11. The Stockholm declaration. 2006 http://www.wada-ama.org/en/dynamic.ch2? pageCategory.id=530
12. Rugby team converts to give gene tests a try. C Dennis, Nature 2005 434 260 260 10.1038/434260a 15772612
13. Here come the Olympics. D Kennedy, Science 2004 305 573 10.1126/science.305.5684.573 15286330
14. Designer androgens in sport: when too much is never enough. DJ Handelsman, Sci STKE 2004 2004 e41 http://stke.sciencemag.org/cgi/content/ abstract/stke.2442004pe41
15. Drugs bust reveals athletes' secret steroid. J Knight, Nature 2003 425 752 10.1038/425232a 14574369
16. www.olympic.org. 2007 http://www.olympic.org
17. Use of multiple drugs among adolescents who use anabolic steroids. RH DuRant VI Rickert CS Ashworth C Newman G Slavens, N Engl J Med 1993 328 922 926 10.1056/NEJM199304013281304 8446139
18. Performance-enhancing: substances and their use among adolescent athletes. JJ Koch, Pediatr Rev 2002 23 310 317 12205298
19. [Doping: epidemiological studies]. P Laure, Presse Med 2000 29 1365 1372 10938696
20. Drugs, recreational drug use and attitudes towards doping of high school athletes. P Laure T Lecerf A Friser C Binsinger, Int J Sports Med 2004 25 133 138 10.1055/s-2004-819946 14986197
21. The use of anabolic-androgenic steroids by Canadian students. P Melia A Pipe L Greenberg, Clin J Sport Med 1996 6 9 14 10.1097/00042752-199601000-00004 8925377
22. Risk behaviours for HIV and hepatitis infection among anabolic-androgenic steroid users. SJ Midgley N Heather D Best D Henderson S McCarthy JB Davies, AIDS Care 2000 12 163 170 10.1080/09540120050001832 10827856
23. False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. M Beullens JR Delanghe M Bollen, Blood 2006 107 4711 4713 10.1182/blood-2006-01-0028 16493001
24. Ethical dilemmas in medical innovation and research: distinguishing experimentation from practice. N Fost, Semin Perinatol 1998 22 223 232 10.1016/S0146-0005(98)80038-4 9650230
25. Is it possible to prevent sports injuries? Review of controlled clinical trials and recommendations for future work. J Parkkari UM Kujala P Kannus, Sports Med 2001 31 985 995 10.2165/00007256-200131140-00003 11735682
26. The adverse effects of elite competition on health and well-being. A Pipe, Can J Appl Physiol 2001 26 Suppl S192 S201 11897895
27. Soccer injuries : a review on incidence and prevention. A Junge J Dvorak, Sports Med 2004 34 929 938 10.2165/00007256-200434130-00004 15487905
28. Chronic traumatic brain injury associated with boxing. BD Jordan, Semin Neurol 2000 20 179 185 10.1055/s-2000-9826 10946737
29. Catastrophic cervical spine injuries in the collision sport athlete, part 1: epidemiology, functional anatomy, and diagnosis. R Banerjee MA Palumbo PD Fadale, Am J Sports Med 2004 32 1077 1087 10.1177/0363546504265605 15150061
30. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. JM Tokish MS Kocher RJ Hawkins, Am J Sports Med 2004 32 1543 1553 10.1177/0363546504268041 15310585
31. Effects of androgenic-anabolic steroids in athletes. F Hartgens H Kuipers, Sports Med 2004 34 513 554 10.2165/00007256-200434080-00003 15248788
32. Football and doping: study of African amateur footballers. PF Ama B Betnga M Ama V JP Kamga, Br J Sports Med 2003 37 307 310 10.1136/bjsm.37.4.307 12893714
33. Pharmacoepidemiology of anabolic androgenic steroids: a review. I Thiblin A Petersson, Fundam Clin Pharmacol 2005 19 27 44 10.1111/j.1472-8206.2004. 00298.x 15660958
34. Postoperative course and anabolic-androgenic steroid abuse - a case report. M Medras U Tworowska P Jozkow A Dumanski A Dubinski, Anaesthesia 2005 60 81 84 10.1111/j.1365-2044.2004.03998.x 15601278
35. Self-Reported Attitudes of Elite Athletes Towards Doping: Differences Between Type of Sport. A Alaranta H Alaranta J Holmila P Palmu K Pietila I Helenius, Int J Sports Med 2006 27 842 6 10.1055/s-2005-872969 16586338
36. R Voy, Drugs, Sport and Politics Champaign, Leisure Press 1991
37. Doping with artificial oxygen carriers: an update. YO Schumacher M Ashenden, Sports Med 2004 34 141 150 10.2165/00007256-200434030-00001 14987124
38. E Parens, Enhancing Human Traits: Ethical and Social Implications Washington D.C., Georgetown University Press 1998
39. Doping Test Reveals High Concentrations of Salbutamol in a Swiss Track and Field Athlete. C Schweizer M Saugy M Kamber, Clin J Sport Med 2004 14 312 315 10.1097/00042752-200409000-00018 15377972
40. Use of beta2 agonists in sport: are the present criteria right? OJ Naranjo RA Centeno Prada M Carranza M.D., Br J Sports Med 2006 40 363 366 10.1136/bjsm.2005.024513 16556795
41. Medial collateral ligament reconstruction of the elbow using the docking technique. JT Rohrbough DW Altchek J Hyman RJ Williams III JD Botts, Am J Sports Med 2002 30 541 548 12130409
42. JR Gusfield, Symbolic crusade status politics and the American temperance movement Urbana, University of Illinois Press 1963
43. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. M Parssinen U Kujala E Vartiainen S Sarna T Seppala, Int J Sports Med 2000 21 225 227 10.1055/s-2000-304 10834358
44. Use of performance-enhancing substances. J Gomez, Pediatrics 2005 115 1103 1106 10.1542/peds.2005-0085 15805399
45. Doping and the child: an ethical policy for the vulnerable. A Miah, Lancet 2005 366 874 876 10.1016/S0140-6736(05)67296-0 16153998
46. Steroids. Building a better you? B Berlin, N J Med 1999 96 49 51 15038237
47. Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. C Aitken C Delalande K Stanton, Drug Alcohol Depend 2002 65 303 308 10.1016/S0376-8716(01)00174-0 11841901
48. Anti-doping policy in sport: The politics of international policy co-ordination. B Houlihan, Public Administration 1999 77 311 334 10.1111/1467-9299.00156
49. www.swissolympic.ch. 2007 http://www.swissolympic.ch
50. www.uci.ch. 2007 http://www.uci.ch
51. Marijuana as doping in sports. DR Campos M Yonamine RL Moraes Moreau, Sports Med 2003 33 395 399 10.2165/00007256-200333060-00001 12744713
52. Current trends in altitude training. RL Wilber, Sports Med 2001 31 249 265 10.2165/00007256-200131040-00002 11310547
53. Space-tech at the Paralympics - Czyz takes Gold in 100 m sprint. 2007 http://www.esa.int/esaCP/SEM16S9DFZD_FeatureWeek_0.html
54. A Miah SB Eassom, Sport Technology: History, Philosophy & Policy. Research in Philosophy & Technology. Oxford, Elsevier Science 2002
55. Gene-talk and sport-talk: A view from the radical middle ground. H Sheridan B Pasveer I Van Hilvoorde, Eur J Sport Sc 2006 6 223 230 10.1080/17461390601012611
56. Gene doping. HJ Haisma O de Hon, Int J Sports Med 2006 27 257 266 10.1055/s-2006-923986 16572366
57. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. WW Franke B Berendonk, Clin Chem 1997 43 1262 1279 9216474
58. Doped East German athletes to receive compensation. A Tuffs, BMJ 2002 324 1544 12089087 10.1136/bmj.324.7353.1544/b
59. The coercive power of drugs in sports. TH Murray, Hastings Cent Rep 1983 13 24 30 6629745
60. I Waddington, Sport, Health and Drugs: A Critical Sociological Perspective Leicester, E and FN Spon 2000